01 January 2022 → 31 December 2025
Regional and community funding: Special Research Fund
Medical and health sciences
- Single-cell data analysis
- Cancer biology
- Cancer therapy
Neuroblastoma single cell analysis combination therapy immunomodulatio
This study aims to identify and explore novel therapeutic targets for combination therapy and immunomodulation in neuroblastoma, a pediatric tumor of the developing peripheral nervous system. The teams will collaboratively apply novel technology in functional cancer genetics, oncoimmunology, animal modeling and liquid biopsy analysis. This program will yield novel therapeutic strategies with better survival and reduced adverse side effects.